Knowledge is the first and last step to investing

Biocon receives UK Healthcare Department’s approval for Diabetes drug Liraglutide, becoming the first Generics company to obtain approval for Diabetes drug in the UK.

Recommended For You

Next Post
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?